1-Seyed Alavi GH. [The Menopausal Period]. Tehran: Nashre Jahad; 1995. p.4. [In Persian]
2-Speroff L, Glass RH, Kase NG. Clinical gynecology endocrinology and Infertility. 5thed. Baltimor, MD: Williams & Wilkins; 2005. p. 621-777.
3-Shifren Jl, Schiff I. Menopause. In: Berek JS. Berek & Novak's Gynecology. 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. P. 1323-42.
4-Kazemian A, Broomandfar KH, Ghanadi AR, Noorian K. [Effects of valerian on menopausal hot flash]. J Shahre-Kord Med Univ 2006;8(2): 35-40. [In Persian]
5-Sadat Hashemi SM, Ghorbani R, Kalalian H, Majdabadi Askari H, Kaveei B, Khalajabadi Farahani F. [Parametric Estimation of Age Patterns at Natural Menopause in shahrood; Semnan Province, Iran, 2007]. Semnan University Med Sci J 2009;3:29-35. [In Persian]
6- Speroff L, Marc A, Fritz MA. Menopause and the perimenopausal transition. 2005:621-88.
7-Costantino D, Guaraldi C. Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: an open, non-controlled clinical trial. Eur Rev Med Pharmacol Sci 2008;12(6):411-6.
8-Palacios S. Managing urogenital atrophy. Maturitas 2009;63(4):315–8.
10-Marx P, Schade G, Wilbourn S, Blank S, Moyer DL, Nett R. Low-dose (0.3 mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis. Maturitas 2004;47(1):47–54.
11-Carpenter JS . The Hot Flash Related Daily Interference Scale : a tool for assessing the impact of hot flashes on quality of life following breast cancer .J Pain Symptom Manage 2001;22(6):979-89.
12-Ekin M, Yasar L, Savan K, Temur M, Uhri M, Gencer I, et al. The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Arch Gynecol Obstet 2011;283(3):539-43.
13-Checa MA, Garrido A, Prat M, Conangla M, Rueda C, Carreras R. A comparison of raloxifene and calcium plus Vitamin D on vaginal atrophy after discontinuation of long-standing postmenopausal hormone therapy in osteoporotic women. A randomized, masked-evaluator, one-year, prospective study. Maturitas 2005;52(1):70–7.
14-Morali G, Polatti F, Metelitsa EN, Mascarucci P, Magnani P,
Marrè GB. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy.
Arzneimittelforschung 2006;56(3):230-8.
15-Le Donne M, Caruso C, Mancuso A, Costa G, Iemmo R, Pizzimenti G, et al. The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause. Arch Gynecol Obstet 2011;283(6):1319-23.
16-Karaosmanoglu O, Cogendez E, Sozen H, Asoglu MR, Akdemir Y, Eren S. Hyaluronic acid in the treatment of postmenopausal women with atrophic vaginitis. Int J Gynecol Obstet 2011;113(2):156-7.
18-McLAREN HC. Vitamin E in the menopause. Br Med J 1949;2(4641):1378–81.